Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Zymeworks Inc
About ZYME
Zymeworks Inc. is a global clinical-stage biotechnology company. The Company is developing a diverse pipeline of multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases such as cancer, autoimmune and inflammatory diseases (AIID). The Company engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s Azymetric technology. It has entered into separate agreements with BeiGene, Ltd. and Jazz Pharmaceuticals Ireland Limited, granting each exclusive rights to develop and commercialize zanidatamab in different territories. It is advancing a pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. The Company has two clinical-stage product candidates: ZW171 and ZW191. Its preclinical product candidates include ZW251, ZW220, ZW209, and ZW1528.
Find out what a historical investment in Zymeworks Inc would be worth today using our ZYME stock calculator.
Market Capitalisation
$1.78B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
542.86K
High today
$25.20
Low today
$24.27
Open price
$24.40
52-week high
$29.75
52-week low
$11.02
Ready to start your investing journey with Stake?
Open an accountHow do I buy ZYME shares in Australia?
Buying ZYME shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Zymeworks Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ZYME
What is the ticker symbol of Zymeworks Inc?
The ticker symbol for Zymeworks Inc is ZYME.
How much is one share of ZYME?
One share of ZYME is valued at $24.95 as of 20 May 2026.
What is the market capitalisation of Zymeworks Inc ZYME?
As of 20 May 2026 Zymeworks Inc has a market cap of $1.78B.
What is the 52-week high for Zymeworks Inc stock?
The Zymeworks Inc 52-week high stock price is $29.75.
What is the 52-week low for Zymeworks Inc stock?
The Zymeworks Inc 52-week low stock price is $11.02.
Can I buy ZYME shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ZYME shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ZYME on Stake
- Buy ZYME from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ZYME from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ZYME related stocks